FREDUN PHARMACEUTICALS
Back to Income Statement
|
FREDUN PHARMACEUTICALS Last 5 Year Revenue History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹275 Cr | ₹224 Cr | ₹134 Cr | ₹11,277,136 Cr | ₹97 Cr |
What is the latest Revenue of FREDUN PHARMACEUTICALS ?
Year | Revenue |
---|---|
Mar2024 | ₹275 Cr |
Mar2023 | ₹224 Cr |
Mar2022 | ₹134 Cr |
Mar2021 | ₹11,277,136 Cr |
Mar2020 | ₹97 Cr |
How is Revenue of FREDUN PHARMACEUTICALS Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹275 Cr | 22.37 | |
Mar2023 | ₹224 Cr | 67.64 | |
Mar2022 | ₹134 Cr | -100.00 | |
Mar2021 | ₹11,277,136 Cr | 11,623,895.95 | |
Mar2020 | ₹97 Cr | - |
Compare Revenue of peers of FREDUN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
FREDUN PHARMACEUTICALS | ₹331.9 Cr | 5.6% | 5.9% | -18.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹410,142.0 Cr | -1.5% | 9.1% | 9.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹145,762.0 Cr | -4.9% | -0.6% | 59.1% | Stock Analytics | |
CIPLA | ₹114,322.0 Cr | -1.8% | 1% | 0.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹111,171.0 Cr | 1.6% | 12.1% | 21.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹92,603.7 Cr | -3% | -0.9% | -7.7% | Stock Analytics |
FREDUN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
FREDUN PHARMACEUTICALS | 5.6% |
5.9% |
-18.1% |
SENSEX | -2.9% |
3.1% |
1.8% |
You may also like the below Video Courses